Web Results


Apr 4, 2018 ... 325), all Plaintiffs are required to produce a complete and verified. Plaintiff Fact ...... Von Braun, Betty v. Sanofi ..... Sanofi U.S. Services Inc. et al.


May 4, 2018 ... Accord Healthcare, Inc., a streamlined service procedure is in PTO 29 (Rec. Doc. ..... Lucy v. Sanofi US LLC, et al.1 ...... Von Braun, Betty v.


Jan 3, 2017 ... Amgen Inc. et al v. Sanofi et al, No. 1:2014cv01317 - Document 389 (D. Del. 2017) case opinion from the District of Delaware US Federal ...


Rangel v. Sanofi Aventis U.S., LLC et al, No. 6:2010cv01359 - Document 39 (D. Kan. 2012) case opinion from the District of Kansas US Federal District Court.


May 25, 2018 ... MARCUS CREIGHTON, et al., individually ... COMPANY, ... services representatives (“FSRs”) with respect to compensation and other ... employment discrimination class action, Bellifemine v. Sanofi-Aventis U.S. LLC, 2010 WL.


Feb 2, 2018 ... All vaccines routinely recommended for children 6 years of age and younger in the U.S. are ... However, the use of thimerosal as a preservative in U.S. FDA- licensed .... Sanofi Pasteur Inc. 0.01% (12.5 mcg/0.25 mL dose, 25 mcg/0.5 mL dose)3. Fluzone ... Christensen DL, Baio J, Van Naarden Braun K, et al.


Jul 25, 2017 ... 0, TCT GGA CCC ATT CCT TCT TG, Mouse, Hung et al., 2015 ... Rancho Dominguez, CA, United States) against deionized water for 3 days. ..... tested by Sanofi-Pasteur (CDIFFENSETM) (Sougioultzis et al., 2005; Foglia et al., 2012). .... [Cross Ref]; Braun V., Hundsberger T., Leukel P., Sauerborn M., von ...


Apr 27, 2018 ... Any of the vaccine formulations licensed in the United States can be used in an ..... and 1922–1949, passive reports to the U.S. Public Health Service. ... During 2004–2016, among all infants hospitalized for pertussis, .... DT, No trade name, Sanofi Pasteur, Inc. ...... Schmitt HJ, von König CH, Neiss A, et al.


Associates, Inc., a biotechnology and life sciences marketing research ... Biopharmaceutical Products in the U.S. Market, now in its 12th Ed, .... perceptions of perfusion/continuous vs. fed-batch are lagging, and likely reflect ..... 4) C. Fenge et al., in “Animal cell technology: Development, processes and products”, Butterworth-.